EHA Pediatric Hemato-Oncology Course programme

April 10, 202414:00–17:30: Red Cell and ConsultativeWelcome and presentation of the course.  Aims, expectations, and a brief look back. Presenters and topics
M. de Montalembert: Difficult management problems in sickle cell disease
M. D.

Helping to shape Europe’s clinical trials landscape: EHA selected for ACT EU advisory group

Improving the design, efficiency and effectiveness of clinical trials is the objective of the Accelerating Clinical Trials in the European Union (ACT EU) initiative.

Computational Biology Training in Hematology Hall of Fame

A Special Coach for the Cantera 2024

A unique tutorial for young hematologists, co-sponsored by the EHA Lymphoma Group and the Fondazione Italiana Linfomi. DatesMay 14 to May 17, 2024. LocationLecce, Italy. TopicHow the utilization of cellular therapy strategies looks for lymphomas in 2024.

EHA-ECL led statement calls for protection of the Hospital Exemption

The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.

Multi-center acute myeloid leukemia study

An SWG Grant-supported project initiated by EHA's SWG on Acute Myeloid Leukemia.

Standards for functional precision medicine project

An SWG Grant-supported project initiated by EHA's SWG on Precision Hematology.

Splenic marginal zone lymphoma study

An SWG Grant-supported project initiated by the EHA Lymphona Group.